The goal of the current study was to evaluate whether circulating zinc levels, at the time of diagnosis, and polymorphisms in SOD2, CAT and GPX1 are associated with survival among laryngeal cancer patients. This evidence concerns the gene GPX1 and laryngeal carcinoma.